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Editorial on the Research Topic
The HSP70 Molecular Chaperone Machines
The HSP70s belong to a small family of highly conserved ∼70 kDa enzymes that can use the
energy of ATP-hydrolysis to modify the structure, and consequently the function, of specific
native proteins, and to unfold, solubilize, and thereby reduce the cellular concentration of harmful
misfolded proteins (Finka et al., 2016). Particular HSP70s are expressed constitutively in the cytosol
of bacteria and in all the ATP-containing compartments of eukaryotic cells. In unstressed bacteria,
plant, and animal cells, HSP70s are 0.5–2% of the total protein mass (Finka and Goloubinoff, 2013).
They form the central hub of the chaperone network that controls all aspects of cellular protein
homeostasis: protein de novo synthesis, protein translocation across membranes, native folding,
and oligomer assembly. HSP70s also participate in the active removal of toxic protein aggregates
by actively converting them into harmless degraded peptides, or into natively refolded functional
proteins (Calamini and Morimoto, 2012; Finka et al., 2016).
In immortalized human cancer cells and in naïve rat livers cells for example, HSPA8 is the
major HSP70 species that is constitutively expressed in the cytosol, accounting for about half of
the total mass of the HSP70s (Finka and Goloubinoff, 2013). In heat-shocked cells, particular
HSP70s accumulate. Hence, following a 4 h mild fever-like heat-shock at 41◦C, the total mass of
the HSP70s in Jurkat cells increases 1.6-folds, from ∼0.7% (at 37◦C) to ∼1.1% (Finka et al., 2015).
Thus, although sharing 90% sequence identity with HSPA8, the cytosolic HSPA1A, which generally
remains undetected in unstressed tissues, strongly accumulates during various abiotic stresses
(Finka et al., 2015). Noticeably, non-heat-shocked cancer cells generally express constitutively
abnormally elevated levels of HSPA1A that may even exceed the naturally high amounts of HSPA8.
High expression levels of HSPA1A in otherwise unstressed tissues is thus a hallmark of malignancy
and of poor survival outcome (Feder et al., 1992; Finka and Goloubinoff, 2013; Yang et al., 2015).
The endoplasmic reticulum HSP70, HSPA5 (called BIP), and the mitochondrial HSP70, HSPA9
(calledmortalin) are the nextmost abundant HSP70 species. As in the case of cytosolic HSPA8, their
concentration may also increase in response to heat-shock (Finka et al., 2015). In addition to their
function in protein quality control, they act as pulling motors that import cytosolic polypeptides
into their respective organelles.
Assisted by over 30 different J-domain cochaperones in eukaryotes (Dekker et al.) and various
nucleotide exchange factors (NEFs) (Bracher and Verghese), the HSP70s can control a great
number of housekeeping cellular processes. They can use the energy of ATP-hydrolysis to
convert active (alter)native protein complexes into differently active native polypeptides. Thus,
Abbreviations: SBD, Substrate binding domain; NBD, Nucleotide binding domain; NEF, Nucleotide Exchange Factor;
Natively folded proteins, proteins folded in a functional native conformation; (Alter)natively folded proteins, proteins folded
in a different, albeit still native conformation.
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at the exit of ribosomes, specific HSP70s can pull and
regulate the de-novo folding of nascent polypeptides. Others
can pull and unfold cytosolic polypeptides necessary for their
translocation acrossmembranes into organelles. Yet other HSPAs
can regulate the post-translocation folding and assembly of
(alter)natively folded protein complexes and coordinate their
timely disassembly into differently active sub-complexes, as in
the case of clathrin cages and triskalions (Sousa and Lafer; De
Los Rios and Goloubinoff, 2016). HSP70s can also determine
the lifespan of native cellular proteins by timely targeting them
to chaperone-gated proteases, as in the case of the bacterial
transcription factor σ32, which is targeted by DnaK to the FtsH
protease (Rodriguez et al., 2008; VanPelt and Page, 2017). HSP70s
also target misfolded proteins to the lysosome in a process called
chaperone-mediated-autophagy (Cuervo and Wong, 2014).
Some HSP70s can act as ATP-fuelled molecular motors that,
together with specific cochaperones, such as their eukaryotic
HSP110 cognates (Mattoo et al., 2013; Nillegoda and Bukau)
or the ClpB/HSP104s, which are non-cognate AAA+ ATPases
(Mogk et al., 1999), can solubilize stable aggregates and convert
them into harmless natively refolded or degraded polypeptides.
Thus, together, the HSP70s form a powerful cellular defense
network against harmful misfolded proteins. HSP70s failure to
be expressed, or to function in aging metazoan cells, directly
correlates with the late age onset of severe human degenerative
diseases, such as Parkinson, Alzheimer, and type 2 diabetes that
are associated to the accumulation of misfolded proteins in the
damaged tissues (Hartl, 2016).
In this research topic, several reviews tackled from different
complementing angles the central question: how may the
members of a small class of relatively simple two-domain 70 kDa
molecules use ATP to drive dramatic conformational changes,
in so diverse aggregated, misfolded, and alternatively folded
polypeptides, and thus control such a great number of different
housekeeping and stress related biological functions in the
cell?
In their review “Insight into the molecular mechanism of
allostery in HSP70s,” Mayer and Kityk described the intricate
molecular paths of various allosteric signals during the HSP70
ATPase cycle, leading to dramatic movements of the two
subdomains that bind the polypeptide substrates. They focused
on specific residues that are involved in various key allosteric
signals in the chaperonemolecule, such as the signal that is issued
by the substrate upon binding to the base of the substrate binding
domain (SBD) to induce ATP hydrolysis in the nucleotide
binding domain (NBD). Another signal is issued by the NBD
to induce the closure of the SBD’s lid onto its base, and yet
another signal that is issued by the NEF-triggered NBD to induce
the sequential release of the ADP from the NBD and of the
structurally modified polypeptide from the SBD.
In their review “Multi-layered molecular mechanisms
of polypeptide holding, unfolding and disaggregation by
HSP70/HSP110chaperones” Finka et al. addressed the apparent
consequences of the coordinated subdomain movements in
the HSP70 molecule during the ATPase cycle, on the bound
misfolded or (alter)natively folded polypeptide substrates,
leading to their conversion into native or degraded polypeptides.
Two complementing mechanisms are being discussed: (1)
unfolding by direct clamping, in which the closure of the SBD
lid onto a bulky misfolded protein segment and its consequent
squeezing against the SBD base would result in the local
unfolding of the bound misfolded segment. (2) Unfolding by
entropic pulling, in which the distal binding of several HSP70
molecules onto the same misfolded polypeptide, and their
ensuing independent dangling motions would generate a force
capable of unfolding by entropic pulling the misfolded segments
that are in between two HSP70-bound sites (Goloubinoff and De
Los Rios, 2007).
The various allosteric paths leading to sub-domain
movements and their possible effects on a bound misfolded
substrate can be summarized as follow: In an ATP-bound
HSP70, there is a tight crosstalk between a J-domain from a
DNAJ co-chaperone anchored in the NBD, and a hydrophobic
misfolded polypeptide substrate newly bound to the wide-open
SBD. Both then concomitantly trigger ATP hydrolysis in the
NBD and the closing of the SBD’s lid that applies a local pressure
onto a bulky misfolded segment in the bound substrate leading,
upon tight engulfment by the SBD, to the extensive unfolding
of the substrate (Sharma et al., 2010; Mashaghi et al., 2016).
The subsequent transient binding of a NEF to the distal lobes
of the NBD then triggers ADP release from the NBD and the
opening of the protein-binding lid, allowing the newly unfolded
polypeptide to dissociate and spontaneously refold to the native
state.
However effective an unfolding nanomachine may the HSP70
molecule be, it remains quiet ineffective at choosing its substrates
among the many different polypeptides in need to be structurally
modified. Substrate discrimination by the HSP70 system is
predominantly achieved by the J-domain co-chaperones that
initially interact with the different substrates and at the same time
bind the HSP70s through their J-domain.
In their review “DNAJs: more than substrate delivery to
HSPA,” Dekker et al. highlighted the crucial role of J-domain
cochaperones to the protein quality control of metazoan cells.
DNAJs can target HSP70s onto misfolded, aggregated, or
specific alternatively folded protein substrates, to be unfolded,
refolded, or ultimately degraded by chaperone-gated proteases.
In addition, specific DNAJs are involved in the unidirectional
translocation of cytosolic pre-proteins across membranes to the
ER, the mitochondria, the lysosome, and in plants also the
chloroplast and the peroxisome. Other DNAJs carry unique anti-
aggregation functions of their own, as in the case of mammalian
DNAJB6, which is a very potent anti-aggregation chaperone that
prevents the formation of toxic polyglutamine species that cause
severe degenerative diseases, such as Huntington’s chorea.
In their review, “Metazoan HSP70-based protein
disaggregases: emergence and mechanisms,” Nillegoda and
Bukau further dwelt on the key role of J-domain cochaperones
of HSP70, in particular the human DNAJA2 and DNAJB1,
which seem to specifically recruit HSC70 and its sequence-
related HSP110 co-chaperone, to form powerful disaggregating
hetero-oligomers capable of solubilizing denatured reporter
proteins, among them, stable alfa-synuclein fibrils (Gao et al.,
2015; Finka et al., 2016). Two putative “clamp and walk” and
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“metazoan nucleation” models are discussed for the HSP70- and
HSP110-mediated disaggregation mechanism.
In contrast to misfolded protein aggregates serving as
substrates to the HSC70-HSP110 disaggregation machinery, in
their review “The role of molecular chaperones in clathrin
mediated vesicular trafficking,” Sousa and Lafer discuss the role
of a specific J-domain cochaperone, auxilin, in the recruitment
of HSC70 and HSP110 to a specific position onto a natively
assembled protein complex: the clathrin cage. There, HSC70
uses ATP to pull and disassemble clathrin coats by a “steric
wedge” mechanism, which is very similar to entropic pulling.
Recently, the same authors brought evidence that loose HSC70
multimers might form and thus join their “steric wedge” entropic
pulling forces to disassemble clathrin cages more efficiency.
HSC70 also sequesters the depolymerized clathrin, implying that
triskelion release must be regulated by HSP110 (Sousa et al.,
2016). Interestingly, in neurons, HSP110 activity as a specific
NEF for HSC70 is regulated upon phosphorylation by a Calcium-
regulated kinase (Ishihara et al., 2003). Thus, following the vesicle
fusion with the plasma membrane and the discharge of their
neuro-transmitters content in the synapse, the transient entry of
Ca2+ ions in the cytosol would be able to precisely signal the
onset of clathrin cage dismantling for triskelion recycling.
In their review “The nucleotide exchange factors of HSP70
molecular chaperones” (Bracher and Verghese), Bracher and
Verghese discussed the large diversity of the eukaryotic NEFs.
In addition to the HSP110s, which are sequence wise-, structure
wise-, and function wise-related to the HSP70s (Mattoo et al.,
2013), there are unrelated HSPBP1/Sil1, BAG domain proteins
and the M-domain of the HSP104 disaggregase cochaperone
(Carroni et al., 2014; Doyle et al., 2015), and the GrpE type of
NEFs to be found in prokaryotes and eukaryotic organelles of
eubacteria origin. Despite their great disparity of structure, the
various NEFs, interact with the same surfaces on the HSP70s:
the tips of the twoNBD subdomains embracing the ADP-binding
pocket.
It should be noted that BAG domain proteins and GrpE do not
have nucleotide binding sites. Moreover, both GrpE and HSP110
were shown to induce polypeptide release, respectively, from
DnaK and HSP70, in the total absence of ATP (Sharma et al.,
2010; Mattoo et al., 2013). Thus, these versatile regulatory co-
chaperones should be called ADP- and substrate-release factors
rather than, nucleotide exchange factors.
Within cells, HSP70s can use ATP to drive structural changes
in other cellular proteins. Yet, extracellular HSP70 is also to be
found at the surface of cells facing the ATP-less outward milieu.
In mammals extracellular HSP70 can stimulate innate immune
responses and facilitate the cross-presentation of immunogenic
peptides, in association with major histocompatibility complex
(MHC) antigens (Shevtsov and Multhoff, 2016).
Providing biological context to this research topic, Przyborski
et al. (Bracher and Verghese) discussed in their review
“Plasmodial HSP70s are functionally adapted to the malaria
parasite life cycle” the role HSP70 in a severe human disease:
malaria. The parasite Plasmodium falciparum encodes for half a
dozen different HSP70s, which are key to the survival and the
pathology of the parasite in its various stages of its development,
in particular for its resistance to high temperatures episodes
during human fever, as well as of low ambient temperature when
dwelling in the salivary glands of the mosquitos.
In conclusion, whereas the lack of an appropriate level
of HSP70 expression in metazoan neural and muscle tissues,
without stress and following biotic and abiotic stresses, has
been associated to the onset of excessive damaging apoptosis,
leading to degenerative tissue loss and accelerated aging (Kimura
et al., 2007; Ben-Zvi et al., 2009; Morimoto and Cuervo, 2014),
excessive accumulation of HSP70s has been linked to therapeutic
resistance of carcinomas, increased metastasis, and poor survival
outcomes to anti-cancer therapies (Sherman and Gabai, 2015;
Figure 1). Yet, compared to terminally differentiated cells, rapidly
growing embryonic cells that are not cancerous, also express
high HSP70 and HSP90 levels (Jensen et al., 2013). Thus,
the effectiveness of the various HSP70s at maintaining cellular
protein homeostasis and controlling life span likely depends on
yet to be characterized, fine-tuned qualitative differences in the
expression and activation levels of the various HSP70s and their
many J-domain, NEF, and disaggregase cochaperones.
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